FTRE

18.5507.94%
DR

David Ross Smith

Independent Director

Mr. David Ross Smith serves as Independent Director at Fortrea Holdings Inc. since June 15, 2023 and also served as Interim CFO and Principal Financial Officer since July 27, 2026 until September 9, 2026. He had been the Chief Financial Officer and Corporate Executive Vice President of Charles River Laboratories International, Inc. since August 12, 2015 until May 2022. He is responsible for overseeing Accounting, Tax, Treasury, Investor Relations, Internal Audit, Risk Management and Procurement and leads the Company’s global Finance organization. He joined Charles River Laboratories International, Inc. in March 2014. He served as the Chief Accounting Officer of Charles River Laboratories International, Inc. since October 31, 2016 until April 26, 2017 and served as its Corporate Senior Vice President of Global Discovery Services until August 12, 2015. He served as the Chief Executive Officer of the Service Division of Galapagos NV since August 20, 2013. He joined Galapagos from the Cambridge University Hospitals, where he served as Director of Finance. He served as the Chief Financial Officer of Galapagos NV from February 1, 2006 to May 2007. He served as the Chief Financial Officer of Galapagos from 2005 to 2007. At AstraZeneca, he held Marketing Company Chief Financial Officer roles. He serves as a Director of Charles River Discovery Research Services UK Limited (formerly known as BioFocus DPI Ltd). He worked at PricewaterhouseCoopers prior to joining AstraZeneca in 1997, where he worked in various finance and business roles of increasingly greater responsibility. He was Audit Manager to a variety of industries and international clients in Dubai and post qualification as a Chartered Accountant in Leeds he ran several companies in administration. He holds a Degree in Molecular Biophysics from the University of Leeds.

Positions